Project Grant R01DA061850
- This $1,039,420 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support research to study the neuronal ensembles and circuits involved in the facilitation and disinhibition of opioid and alcohol seeking behaviors. The 5-year project, which begins on June 1, 2025 and runs through February 28, 2030, will employ innovative techniques such as single-nucleus RNA sequencing, spatial sequencing, and in vivo...
- This federal Project Grant award for $188,995.00 was provided by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279). The award supports research at the University of Pittsburgh focused on understanding, preventing, and treating substance use disorders. The project aims to develop novel interventions, explore neuroscientific mechanisms of addiction, and improve treatment strategies. The...
- This federal Project Grant award of $623,650 was provided by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant is funding research at Oregon Health & Science University to investigate how adolescent social isolation and disruption of thyroid hormone signaling in the basolateral amygdala may contribute to substance use disorder vulnerability. The project aims to elucidate the...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $608,652 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Scripps Research Institute. The purpose of this 5-year award, with a start date of September 1, 2025, is to conduct data mining and functional validation of the Systematic Characterization of Retroviral Conditions for Health (SCORCH) datasets. The research aims to elucidate the key pathogenic...
- This federal Project Grant award of $237,000 from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), supports research on the lasting effects of early resource scarcity on astrocyte structure and function in the medial prefrontal cortex. The research project, titled "Lasting Effects of Early Resource Scarcity on Cortical Astrocyte Structure and Function", aims to determine how astrocyte morphology and function are affected by a postnatal...
- This $507,000.00 federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research at the Icahn School of Medicine at Mount Sinai to investigate the epigenetic mechanisms underlying cannabis use disorder. The project, running from September 1, 2025 to May 31, 2030, aims to leverage a translational animal model of voluntary THC consumption to study sex differences and individual variability in...
- This federal Project Grant award of $201,250 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research on the synaptic organization of cholinergic interneurons in the nucleus accumbens region of the brain. The study, conducted by New York University (NYU), aims to characterize the diverse excitatory and inhibitory inputs that contact these interneurons and influence their firing patterns. The research combines...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, awarded a $790,937 Cooperative Agreement under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Research Foundation for the State University of New York (RF SUNY), doing business as Sponsored Projects Services. This award supports research to understand the genetic factors that contribute to the transition from recreational to problematic drug use, with the goal of uncovering biological...
- This Project Grant award of $840,425.00 was provided by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, under the Drug Use and Addiction Research Programs (CFDA 93.279). The funding will support research examining the impact of pre- and postnatal substance exposure, maternal distress, and related parent-child interpersonal processes on the development of adolescent risk behaviors, including substance use and delinquency. The research will leverage a...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $1,445,752 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to New York University School of Medicine. The grant, titled "Characterizing Complex OUD Care Trajectories and Outcomes Following Acute Service Utilization: A Population-Based Data Linkage Study," aims to apply novel research approaches to better understand real-world opioid use disorder (OUD)...
This federal Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to examine the relationship between neighborhood conditions, neural circuits, and substance use behaviors across the early life course. The $2,314,254 award to The Research Foundation For The State University Of New York, doing business as Suny Downstate Health Sciences University, will fund a longitudinal study to investigate the multifactorial etiology of substance use disorders, including the complex interactions between individual socioeconomic status, neighborhood characteristics, neurodevelopmental factors, and genetic vulnerabilities. The research aims to utilize sophisticated methods to understand pathways of substance use disorder risk, particularly in light of changing cannabis legalization and the ongoing opioid crisis. The project period runs from Sep 30, 2025 to Jun 30, 2029.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $2.3m | 9/19/25 |